semaglutide and birth defects does cause ameliorates metabolic disorders in offspring via regulation of oocyte ROS of pre-pregnancy obesity mice Semaglutide, Fertility & Pregnancy GLP-1 Medications and Pregnancy: When

Retatrutide is a promising medication currently undergoing clinical trials for obesity treatment, but it is not yet FDA-approved

Visser M, Goodpaster BH, Kritchevsky SB, Newman AB, Nevitt M, Rubin SM, Simonsick EM, Harris TB

You already know the names Ozempic, Wegovy, Mounjaro, Zepbound

Furthermore, GLP-1 agonists offer health benefits that transcend weight management, including improved glycemic control and potential protective effects against cardiovascular diseases

Mutations in the GLP1R gene and in another gene GIPR, which is related to insulin secretion and energy production were associated with medication-related nausea or vomiting